Actively Recruiting

Phase Not Applicable
Age: 40Years - 60Years
FEMALE
NCT06238700

Study on Allopregnanolone and Depression in Women Across the Menopause Transition

Led by Beth Israel Deaconess Medical Center · Updated on 2026-05-14

80

Participants Needed

1

Research Sites

172 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims to identify how enhanced allopregnanolone activity (via pregnenolone) affects behavior and neurobiology that may underlie perimenopausal depression.

CONDITIONS

Official Title

Study on Allopregnanolone and Depression in Women Across the Menopause Transition

Who Can Participate

Age: 40Years - 60Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Healthy women ages 40 to 60 years in the menopause transition
  • Depressive symptoms
  • Psychotropic medications are allowed if the dose is stable prior to screening and throughout the study
  • Able to read Arabic numerals and perform simple arithmetic
  • Able to provide written informed consent
Not Eligible

You will not qualify if you...

  • Systemic hormone therapy
  • Contraindicated medications with pregnenolone
  • Systemic corticosteroid use
  • Other primary psychiatric illnesses
  • Current suicidal thoughts
  • Active substance use disorders
  • Unstable medical conditions
  • Obstructive sleep apnea or other primary sleep disorders
  • Abnormal liver or kidney function
  • Allergy to progesterone, exogenous allopregnanolone, or pregnenolone
  • History of head injury causing loss of consciousness longer than 20 minutes
  • Cannot comply with barrier contraceptive methods
  • Known intellectual disability
  • Investigator judgment that participation poses substantial risk due to medical or psychiatric condition
  • Current or recent participation in other clinical trials that may interfere with this study
  • Inability to comply with study procedures

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

Actively Recruiting

Loading map...

Research Team

A

Aleta Wiley, MPH

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here